From StockStory: 2025-04-25 14:39:00

Shares of Avantor (NYSE:AVTR) dropped 21.2% after reporting a weak first-quarter 2025 performance with sales falling 6% from last year. Lab Solutions declined 8%, while Bioscience Production slipped slightly. Management raised cost savings target to $400 million by 2027 to address performance issues. The market reacted significantly to this news, marking a rare big move for the company. Avantor is down 40.5% YTD and trading 54.5% below its 52-week high. Investors who bought shares 5 years ago would see a 11.24% loss. Consider the impact of generative AI on large corporations and explore semiconductor stocks.



Read more at StockStory: Why Avantor (AVTR) Shares Are Falling Today